Hostname: page-component-f554764f5-qhdkw Total loading time: 0 Render date: 2025-04-13T17:06:35.920Z Has data issue: false hasContentIssue false
  • English
  • Français

Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity

Published online by Cambridge University Press:  03 January 2018

Matthew Hotopf ,
Rebecca Hardy  and
Glyn Lewis
Matthew Hotopf*
Affiliation:
Department of Psychological Medicine, King's College School of Medicine and Dentistry and Institute of Psychiatry
Rebecca Hardy
Affiliation:
Department of Epidemiology and Public Health, University College London Medical School, 119 Torrington Place, London WCIE 6BT
Glyn Lewis
Affiliation:
Division of Psychological Medicine, University of Wales College of Medicine, Heath Park, Cardiff CF4 4XN, Wales
*
Dr Matthew Hotopf, Department of Psychological Medicine, King's College School of Medicine and Dentistry and Institute of Psychiatry, 103 Denmark Hill, London SE5 8AZ
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Previous meta-analyses suggest that individuals treated with serotonin-specific reuptake inhibitors (SSRIs) in randomised controlled trials (RCTs) are less likely to discontinue treatment than those on tricyclic antidepressants. This metaanalysis investigates whether this is due to the frequent use in RCTs of older reference tricyclics (imipramine and amitriptyline), which may have worse side-effects than more recent compounds.

Methods

A meta-analysis of RCTs comparing tricyclic and heterocyclic antidepressants with SSRIs in the treatment of depression.

Results

The overall odds ratio of discontinuation on tricyclic/heterocyclic antidepressants compared with SSRIs was 0.86 (95% CI 0.78–0.94). The odds ratio for reference tricyclics was 0.82 95% CI 0.72–0.23), newer tricyclics 0.89 (95% CI 0.74–1.06), and heterocyclics 1.02 (95% CI 0.78–1.35). The pooled advantage of SSRIs over tricyclics was maintained whether the population studied consisted of younger adults or only the elderly. No differences in discontinuation rates were detected between the SSRIs.

Conclusions

The lower rate of discontinuation in patients on SSRIs may be due to the use of old tricyclics (which have worse side-effects) as reference compounds. The SSRIs do not show a statistically significant difference in discontinuation rates when compared with newer tricyclics or heterocyclics.

Type
Papers
Information
The British Journal of Psychiatry , Volume 170 , Issue 2 , February 1997 , pp. 120 - 127
Copyright
Copyright © 1997 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Adams, C. E., Power, A., Frederick, K., et al (1994) An investigation of the adequacy of MEDLINE searches for randomized controlled trials (RCTs) of the effects of mental health care. Psychological Medicine. 24, 741–748.CrossRefGoogle ScholarPubMed
Altamura, A. C., De Novellis, F., Guercetti, G., et al (1999) Fluoxetine compared with amitriptyline in elderly depression; a controlled clinical trial. International Journal of Clinical Pharmacology Research, 9, 391–396.Google Scholar
Amin, M. M., Ananth, J. V., Coleman, B. S., et al (1984) Fluvoxamine: antidepressant effects confirmed in a placebocontrolled international study Clinical Neuropharmaoclogy 7(suppl. I) 580 581.Google Scholar
Amore, B., Bellini, M., Berardi, D., et al (1989) Double blind comparison of fluvoxamine and imipramine in depressed patients. Current Therapeutic Research, 46, 815–820.Google Scholar
Anderson, l. M. & Tomenson, B. M. (1995) Treatment discontinuation with selective serotonin reputake inhibitors compared with tricyclic antidepressants: a meta-analysis. British Medical Journal, 310, 1433–1438.CrossRefGoogle Scholar
Arminen, S. L., Ikonen, U., Pulkkinen, P., et al (1994) A 12–233k double-blind multi-centre study of paroxetine and imipramine in hospitalized depressed patients. Acta Psychiatrica Scandinavica. 89, 382–389.CrossRefGoogle ScholarPubMed
Bascara, B. (1989) A double blind study to compare the effectiveness and tolerability of paroxetine and amitriptyline in depressed patients. Acta Psychiatrica Scandinavica. 80(suppl. 350)141–142.CrossRefGoogle Scholar
Battegay, R., Hager, M. & Rauchfleisch, U. (1985) Doubleblind comparative study of paroxetine and amitriptyline in depressed patients of a university psychiatric outpatient clinic. Neuropsychobiology, 13, 31–37.CrossRefGoogle ScholarPubMed
Beasley, C. M., Holman, S. L. & Potvin, J. H. (1993a) Fluoxetine compared with imipramine in the treatment of inpatient depression: a multicentre trial. Annals of Clinical Psychiatry 5, 199–208.CrossRefGoogle Scholar
Beasley, C. M., Holman, S. L., Potvin, J. H., Sayler, M. E. & Potvin, J. H. (1993b) Fluoxetine versus amitriptyline in the treatment of major depression: a multicenter tnal. International Clinical Psychopharmacology 81 143–149.CrossRefGoogle Scholar
Beriin, J. A., Laird, N. M., Sacks, H. S., et al (1989) A comparison of statistical methods for combining event rates from clinical trials. Statistics in Medicine. 8, 141–151.Google Scholar
Bersani, G., Rapisarda, V., Ciani, N., et al (1994) A double blind comparative study of sertraline and amitriptyline in outpatients with major depressive episodes. Human Psychopharmacohgy 9, 63–68.CrossRefGoogle Scholar
Besancon, G., Cousin, R., Guitton, B., et al (1993) Etude en double aveugle de la mianserine et de la fluoxetine chez des patients deprimes traites en ambulatoire. L'Encephale, 19, 341–345.Google Scholar
Bignamini, A. & Rapisarda, V. (1992) A double-blind multicentre study of paroxetine and amitriptyline in depressed outpatients. International Clinical Psychopharmacohgy 6(suppl 4), 37–41.CrossRefGoogle ScholarPubMed
Bowden, C. L., Schatzberg, A. F., Rosenbaum, A., et al (1993) Fluoxetine and desipramine in major depressive disorder. Journal of Clinical Psychopharmacology 3, 305–311.Google Scholar
Boyer, W. F. & Feighner, J. P. (1993) The financial implications of starting treatment with a selective serotonin reuptake inhibitor or tricyclic antidepressant in drug-naive depressed patients. In Health Economics of Depression (eds Johnsson, B. & Rosenbaum, J.), pp 65–75. London; John Wiley & Sons.Google Scholar
Bramanti, P., Ricci, R. M., Roncari, R., et al (1988) An Italian multicenter experience with fluvoxamine, a new antidepressant drug, versus imipramine. Current Therapeutic Research, 43, 718–724.Google Scholar
Bremner, J. D. (1984) Fluoxetine in depressed patients: a comparison with imipramine. Journal of Clinical Psychiatry 45, 414–419.Google ScholarPubMed
Bressa, G. M., Brugnoli, R. & Pancheri, P. (1989) A double blind study of fluoxetine and imipramine in major depression International Clinical Psychopharmacology 4(supppl I), 69–73.Google ScholarPubMed
Byrne, M. M. (1989) Meta-analysis of early phase II studies with paroxetine in hospitalized depressed patients. Acta Psychiatrica Scandinavica, 80(suppl. 350) 138–139.CrossRefGoogle Scholar
Chouinar, G. (1985) A double-blind controlled trial of fluoxetine and amitriptyline in the treatment of outpatients with major depression, Journal of Clinical Psychiatry 46, 32–37.Google Scholar
Cohn, J. B. & Wilcox, C. (1985) A conrparison of fluoxetine, imipramine and placebo in patients with major depressive disorder Journal of clinical Psychiatry 46, 26–31.Google ScholarPubMed
Cohn, J. B., Wilcox, C., Collins, G., Ashbrook, E., et al (1989) A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder. International Clinical Psychopharmacology 4, 313–322.CrossRefGoogle ScholarPubMed
Cohn, J. B., Wilcox, C., Collins, G., Ashbrook, E., Shrivastava, R., Mendels, J., et al (1990) Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients, Journal of Clinical Psychiatry 51(suppl B), 28–33.Google ScholarPubMed
Corne, S. J. & Hall, J. R. (1990) A double-blind comparative study of fluoxetine and dothiepin in the treatnnent of depression in general practice. International Clinical Psychopharmacology 4, 245 254.CrossRefGoogle Scholar
Delery, J., Rochat, C., Peyron, E., et al (1992) Etude comparative de l'efficacite et de l'acceptabilite de lamineptine et de la fluoxetine chez de patients depressifs majeurs. LEncephale, 18, 257 262.Google Scholar
Danish University Antidepressant Group (1990) Paroxetine: selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study Journal of Affective Disorders, 18, 289–299.CrossRefGoogle Scholar
De Jonghe, F., Ravelli, D. P. & Tuynman-Qua, H. (1991a) Randomized double-blind study of fluoxetine and nnaprotiline in the treatment of major depression. Pharmacopsychiatry 24, 62–67.CrossRefGoogle ScholarPubMed
De Jonghe, F., Ravelli, D. P., Swinkeel, H. & Tuynman-Qua, H. (1991b) A randomized. double blind study of fluvoxamine and maprotiline in treatnnent of depression. Pharmacopsychiatry 24 21–27.CrossRefGoogle Scholar
De Wilde, J. E. M. & Doogan, D. P. (1982) Fluvoxamine and chlorimipramine in endogenous depression. Journal of Affective Disorders. 4 249–259.CrossRefGoogle ScholarPubMed
De Wilde, J. E. M., Doogan, D. P., Mertens, C. & Wakslin, J. S. (1983) Clinical trials of fluvoxamine vs clomipramine with single and three times dosing. British Journal of Clinical Pharnujcology 15(suppl 3), 427–431.Google ScholarPubMed
Debus, J. R., Rush, A. J., Himmel, C. et al (1988) Fluoxetine versus trazodone in the treatment of outpatients with major depression. Journal of Clinical Psychiatry 49, 422–426.Google ScholarPubMed
Der Simonian, R. & Laird, N. (1986) Meta-analysis in clinical trials. Controlled Clinical Trials, 7, 177–188.CrossRefGoogle ScholarPubMed
Dick, P. & Ferrero, E. (1983) A double-blind comparative study on the efficacy of fluvoxamine and clomipramine. British Journal of clinical Pharmacology 15, 419–425.CrossRefGoogle Scholar
Dominguez, R. A., Goldstein, B. J., Jacobson, A. F., et al (1985) A double-blind, placebo controlled study of fluvoxamine and imipramine in depression, purnal of Clinical Psychiatry 46, 84–87.Google ScholarPubMed
Dorman, T. (1992) Sleep and paroxetine: a comparison with mianserin in elderly depressed patients. International Clinical Psychopharmacology 6(suppl. 4) 53–58.CrossRefGoogle ScholarPubMed
Drugs and Therapeutic Bulletin (1993) Selective serotonin reuptake inhibitors for depression. Drugs and Therapeutic Bulletin, 31, 57–58.CrossRefGoogle Scholar
Dunner, D. L., Cohn, J. B., Walshe, T., et al (1992) Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression. Journal of clinical Psychiatry 53(suppl. 2) 57–60.Google ScholarPubMed
Effective Health Care (1993) The treatment of depression in prinnary care. Effective Health Care Bulletin, 5, 1–12.Google Scholar
Fabre, L. F., Scharf, M. B. & Itil, T. M. (1991) Comparative efficacy and safety of nortriptyline and fluoxetine in the treatment of major depression; a clinical study Journal of Clinical Psychiatry 52(suppl. 6) 62–67.Google ScholarPubMed
Falk, W. E., Rosenbaum, J. F., Otto, M. W., et al (1989) Fluoxetine versus trazodone in depressed genatric patiens. Journal of Geriatric Psychiatry and Neurology 2, 208–214.CrossRefGoogle Scholar
Fawcett, J., Zajecia, J. & Kravitz, H. (1989) Fluoxetine vs amitriptyline in adult inpatients with major depressioa Current Therapeutic Research, 45, 821–832.Google Scholar
Feighner, J. P. (1985) A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder Journal of Clinical Psychiatry 46, 369–372.Google ScholarPubMed
Feighner, J. P. & Cohan, J. B. (1985) Double-blind comparative study of fluoxetine and doxepin in geriatric patients with major depressive disorder, Journal of clinical Psychiatry 46, 20–25.Google ScholarPubMed
Feighner, J. P. & Cohan, J. B., Boyer, W. F., Meredith, C. H., et al (1989a) A double-blind comparison of fluoxetine, imipramine and placebo in outpatients with major depression. International clinical Psychopharmacology 4, 127–134.CrossRefGoogle ScholarPubMed
Feighner, J. P. & Cohan, J. B., Boyer, W. F., Meredith, C. H., et al (1989b) A placebo-controlled inpatient comparison of fluvoxamine maleate and imipramine in major depression. International Clinical Psychopharmacology 4, 239–244.CrossRefGoogle ScholarPubMed
Feighner, J. P. & Cohan, J. B., Boyer, W. F., Meredith, C. H., Gardner, E. A., Johnston, J. A., et al (1991) Double-blind comparison of bupropion and fluoxetine in depressed outpatients, Journal of clinical Psychiatry 52, 229–235.Google ScholarPubMed
Feighner, J. P., Cohan, J. B., Boyer, W. F., Meredith, C. H., Gardner, E. A., Johnston, J. A., Cohn, J. B., Fabre, L. F., et al (1993) A study comparing paroxetine placebo and imipramine in depressed patients. Journal of Affective Disorders. 28, 71–79.CrossRefGoogle ScholarPubMed
Ferreri, M. (1989) Fluoxetine versus amipentine in the treatment of outpatients with major depressive disorder. International Clinical Psychopharmacologyi 4(suppl. I).97–101.Google Scholar
Fontaine, R. (1991) The efficacy of sertraline versus imipramine in outpatients with major depression: a six month double-blind, parallel multicenter study European Neuropsychopharmacology I 447.CrossRefGoogle Scholar
Galbraith, R. F. (1988) A note on graphical presentation of estimated odds ratios from several clinical trials. Statistics in Medicine. 7, 889–894.Google Scholar
Gasperini, M., Gatti, F., Beilini, L., et al (1992) Perspectives in clinical psychopharmacology of amitriptyline and fluvoxamine. Neuropsychobiology.26, 186 192.CrossRefGoogle ScholarPubMed
Gonella, G., Baignoli, G. & Ecari, U. (1990) Fluvoxamine and imipramine in the treatment of depressive patients. Current Medical Research Opinions. 12, 177–184.CrossRefGoogle ScholarPubMed
Greeniand, S., & Robins, J. M. (1985) Estimation of a corrvnon effect parameter from sparse follow-up data. Biometrics. 41, 55–68.CrossRefGoogle Scholar
Guelfi, J. D., Dreyfus, J. F., Pichot, P., et al (1983) A double-blind controlled clinical trial comparing fluvoxamine with imipramine. British Journal of Clinical Pharmacology, 15(suppl. 3) 411–417.CrossRefGoogle ScholarPubMed
Guilibert, E., Pelicier, Y., Archambaul, J. C., et al (1989) A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients. Acta Psychiatrica Scandinavica. 80(suppl. 350) 132–134.CrossRefGoogle Scholar
Hamilton, M. (1960) A rating scale for depressioa. Journal of Neumlogy Neurosurgery and Psychiatry, 23, 56–62.CrossRefGoogle Scholar
Harris, B., Szujelecka, T. K. & Anstee, J. A. (1991) Fluvoxamine versus amitnptyline on depressed hospital outpatients: a multicentre double blind comparative trial. British Journal of clinical Research, 2, 89–99.Google Scholar
Henry, J. A. & Martin, A. J. (1987) The risk-benefit assessment of antidepressant drugs. Medical Toxicology 2, 445–462.CrossRefGoogle ScholarPubMed
Hotopf, M., Lewis, G. & Normand, C. (1996) Are SSRIs a cost-effective alternative to tricyclics? British Journal of Psychiatry, 168, 404–409.CrossRefGoogle ScholarPubMed
Hutchinson, D. R., Tong, S., Moon, C. A., et al (1992) Paroxetine in the treatnnent of elderly depressed patients in general practice: a double-blind companson with amrtriptyline. International Clinical Psychopharmacohgy 4(suppl. 4), 43–51.CrossRefGoogle Scholar
Itil, T. M., Shrivastava, R., Mukherjee, S., et al (1983) A double-blind placebo-controlled study of fluvoxamine and imipramine in outpatients with primary depressioa British Journal of Clinical Pharmacology 15, 433–438.CrossRefGoogle Scholar
Jönsson, B. & Bebbington, P. E. (1994) What price depression? The cost of depression and the cost-effectiveness of pharmacological treatnnent. British Journal of Psychiatry 164, 665–673.CrossRefGoogle Scholar
Judd, F. K., Moore, K., Norman, T. R., et al (1993) A multicentre double blind trial of fluoxetine versus amitnptyline in the treatment of depressive illness. Australian and New Zealand Journal of Psychiatry. 27, 49–55.CrossRefGoogle ScholarPubMed
Keegan, D., Bowen, R. C., Blackshaw, S., et al (1991) A comparison of fluoxetine and amitriptyline in the treatment of major depressioa International Clinical Psychopharmacology 6, 117–124.CrossRefGoogle Scholar
Kleinbaum, D. G., Kupper, L. L. & Morgenstern, H. (1982) Epidemiologic Research: Principles and Quantitative Methods. Belmont, CA: Lifetime Learning Publications.Google Scholar
Klok, C. J., Brouwer, G. J., van Praag, H. M., et al (1981) Fluvoxamine and clomipramine in depressed patients. Acta Psychiatrica Scandinavica, 64 I–II.CrossRefGoogle ScholarPubMed
Kuhs, H. & Rudolf, G. A. E. (1989) A double-blind study of the comparative antidepressant effect of paroxetine and amitriptyline. Acta Psychiatrica Scandinavica, 80(suppl. 350), 145–146.CrossRefGoogle Scholar
Lapierre, Y. D., Browne, M., Horn, E., et al (1987) Treatment of major affective disorder with fluvoxamine. Journal of Clinical Psychiatry 48, 65–68.Google ScholarPubMed
Laursen, A, L., Mikkelsen, P. L. & le Fievre Honore, P. (1985) Paroxetine in the treatnnent of depression – a randomired comparison with amitriptyline. Acta Psychiatrica Scandinavica, 71, 249–255.CrossRefGoogle ScholarPubMed
Le Pen, C., Levy, E., Ravily, V., et al (1994) The cost of treatment dropout in depressioa A cost benefit analysis of fluoxetine vs tricyclics. Journal of Affeaive Disorders, 31, 1–18.CrossRefGoogle ScholarPubMed
Levine, S., Deo, R., & Mahadevan, K. (1987) A comparative trial of a new antidepressant fluoxetine. British Journal of Psychiatry 150, 653–655.CrossRefGoogle ScholarPubMed
Linck, C. & Dunbar, G. (1992) An overview of studies comparing the efficacy, safety, and tolerability of paroxetine and clomipramine. Nordic Journal of Psychiatry 46 (suppl. 7), 17–22.CrossRefGoogle Scholar
Lydiard, R. B., Laird, L. K., Morton, A. W., et al (1989) Fluvoxamine, imipramine and placebo in the treatment of depressed outpatients: effects on depressioa. Psychopharmacohgy Bulletin. 25, 68–70.Google Scholar
March, J. S., Kobak, K. A., Jefferson, J. W., et al (1990) A double Wind, placebo-controlled study of fluvoxamine versus imipramine in outpatients with nnajor depression, Journal of Clinical Psychiatry 51, 200–202.Google Scholar
Masco, H. L., & Sheetz, M. S. (1985) Double-blind comparison of fluoxetine and amitriptyline in the treatment of major depressive illness. Advances in Therapy, 2, 275–283.Google Scholar
Mertans, C. & Pintens, H. (1988) Paroxetine in the treatment of depression. A double blind multicentre study versus mianserin. Acta Psychiatrica Scandinavica, 77, 683–688.CrossRefGoogle Scholar
Moiler, H. J., Berzewski, H., Eckmann, F., et al (1993) Double-blind multicenter study of paroxetine and amitriptyline in depressed patients. Pharmacopsychiatry 26, 75–78.CrossRefGoogle Scholar
Montgomery, S. A., Henry, J., McDonald, G., et al (1994) Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates. Intemathnal Clinical Psychopharmacology 9, 47–53.CrossRefGoogle Scholar
Moon, C. A. L., & Jesinger, D. K. (1991) The effects of psychomotor performance of fluvoxamine versus mianserin in depressed patients in general practice. British purnal of Clinical Practice. 45, 259–262.Google ScholarPubMed
Moon, C. A. L., & Jesinger, D. K., Jago, L. W., Wood, K., et al (1994) A double-blind comparison of sertraline and clomipramine in the treatment of major depressive disorder and associated anxiety in general practice., Journal of Psychopharmacology 8, 171–176.CrossRefGoogle ScholarPubMed
Muijen, M., Roy, D., Silverston, T., et al (1988) A comparative clinical trial of fluoxetine, mianserin and placebo in depressed outpatients. Acta Psychiatrica Scandinavica. 78, 384–390.CrossRefGoogle ScholarPubMed
Mullin, J. M., Pandita-Gunawardena, V. R. & Whitehead, A. M. (1994) A double-blind comparison of fluvoxamine and dothiepin in the treatment of nnajor affective disorder. British Journal of Clinical Practice. 42, 51–55.Google Scholar
Nathan, R. S., Peral, J. M., Poilock, B. G., et al (1990) The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine. Journal of Clinical Psychiatry 51, 367–372.Google ScholarPubMed
Nielsen, O. A., Morsing, l., Peterson, J. S., et al (1991) Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurennents. Acta Psychiatrica Scandinavica. 84, 233–241.CrossRefGoogle Scholar
Nielsen, O. A., Morsing, l., Peterson, J. S., Behnke, K., Arup, P., et al (1993) A comparison of fluoxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurennents. Acta Psychiatrica Scandinavica. 84, 233–241.CrossRefGoogle Scholar
Noguera, R., Altuna, R., Alvarez, E., et al (1991) Fluoxetine vs clomipramine in depressed patients: a controlled multicentre trial. Journal of Affective Disorders. 22, 119–124.CrossRefGoogle ScholarPubMed
Norton, K. R. W., Sireling, L. L., Bhat, A. V., et al (1984) A double blind comparison of fluvoxamine, imipramine and placebo in depressed patients, Journal of Affective Disorders, 7, 297–308.CrossRefGoogle ScholarPubMed
Nurminen, M. (1981) Asymptotic efficiency of general noniterative estimators of common relative risk. Biometrika, 68, 525–530.CrossRefGoogle Scholar
øhirberg, S., Christiansen, P. E., Severin, B., et al (1992) Paroxetine and imipramine in the treatment of depressive patients in psychiatric practice. Acta Psychiatrica Scandinavica, 86, 437–444.CrossRefGoogle Scholar
Paykel, E. (1989) The background: extent and nature of the disorder. In Depression: An Integrative Approach (eds. Herbst, K. & Paykel, E.) pp 3–17 Oxford: Heinemann.Google Scholar
Perez, A. & Ashford, J. J. (1990) A double-blind, randomized comparison of fluvoxamine with mianserin in depressive illness. Current Medical Research Opinions, 12, 234–241.CrossRefGoogle ScholarPubMed
Perry, P. J., Garvey, M. J., Kelly, M. W., et al (1989) A comparative trial of fluoxetine versus trazodone in outpatients with major depression., Journal of Clinical Psychiatry 50, 290–294.Google ScholarPubMed
Phanjoo, A., Wonnacott, S. & Hodgson, A. (1991) Doubleblind comparative multicentre study of fluvoxamine and miansenn in the treatment of major depressive episode in elderly people. Acta Psychiatrica Scondinavico. 83, 476–479.CrossRefGoogle ScholarPubMed
Poelinger, W. & Haber, H. (1989) Fluoxetine 40 mg vs maprotiline 75 mg in the treatment of outpatients with depressive disorders. International clinical Psychopharmacohgy., 4(suppl I), 47–50.Google ScholarPubMed
Rahman, M. K., Akhtar, M. J., Salva, N. C., et al (1991) A double-blind, randomised comparison of fluvoxamine with dothiepin in the treatment of depression in elderly patients. British Journal of Clinical Practice. 45, 255–258.Google ScholarPubMed
Reimherr, F. W., Chouinard, G., Cohn, C. K., et al (1990) Antidepressant efficacy of sertraline: a double blind, placebo-and amitriptyline-controlled, multicenter connparison study in outpatients with major depressioan. Journal of Clinical Psychiatry 51 (suppl B), 18–27.Google Scholar
Remick, R. A., Keiler, F. D., Gibson, R. E., et al (1989) A comparison between fluoxetine and doxepin in depressed patients. Current Therapeutic Research. 46, 842–848.Google Scholar
Remick, R. A., Keiler, F. D., Gibson, R. E., & Ciaman, J., Reesal, R., et al (1993) Connparison of fluoxetine and desipramine in depressed outpatients. Current Therapeutic Research. 53, 457–465.CrossRefGoogle Scholar
Remick, R. A., Keiler, F. D., Gibson, R. E., & Ciaman, J., Reesal, R., Oakander, M., et al (1994) Comparison of fluvoxamine and amitnptyline in depressed outpatients. Current Therapeutic Research. 55, 243–250.CrossRefGoogle Scholar
Ropert, R. (1989) Fluoxetine versus clomipramine in major depressive disorders. International Clinical Psychopharmacohgy 4(suppl. I), 89–95.Google ScholarPubMed
Roth, D., Mattes, J., Sheehan, K. H., et al (1990) A doubleblind comparison of fluvoxamine, desipramine and placebo in outpatients with depression. Progress in Neuropsychopharmacology and Biological Psychiatry 14, 929–939.CrossRefGoogle ScholarPubMed
Shrivastava, R., Patel Shrivastava, S. H., Overweg, N., et al (1992) A double blind comparison of paroxetine, imipramine and placebo in major depression, Journal of clinical Psychiatry 53(suppl. 2). 48–51.Google ScholarPubMed
Song, F., Freemantle, N., Sheldon, T. A., et al (1993) Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. British Medical Journal. 306, 683–687.CrossRefGoogle ScholarPubMed
South Wales Antidepressant Drug Trial Group (1988) A double-blind multi-centre trial of fluoxetine and dothiepin in major depressive illness. International Clinical Psychopharmacology. 3, 75–81.CrossRefGoogle Scholar
Stark, P. & Hardison, D. (1985) A review of multicenter controlled studies of fluoxetine vs imipramine and placebo in outpatients with major depressive disorder Journal of clinical Psychiatry, 46, 53–58.Google ScholarPubMed
Stratta, P., Bolino, F., Cupillari, M., et al (1991) A double blind parallel study comparing fluoxetine with imipramine in the treatment of atypical depression. International clinical Psychopharmacology. 6, 193–196.CrossRefGoogle ScholarPubMed
Tamminen, T. T. A. & Lahtinen, V. V. (1989) A double-blind parallel study to compare fluoxetine with doxepin in the treatment of major depressive disorders. International Cinical Psychopharmacology 4(suppl. I), 51–56.Google ScholarPubMed
Taneri, Z. & Kohler, R. (1989) Fluoxetine versus nomifensine in outpatients with neurotic or reactive depressive disorder. International Clinical Psychopharmacology 4(suppl. I), 57–61.Google ScholarPubMed
Thompson, C. (1991) Setraline in a primary care setting In Biological Psychiatry (ed. Anonymous), pp. 863–865. Amsterdam: Elsevier.Google Scholar
Thompson, S. G. & Pocock, S. J. (1991) Can meta-analysis be trusted? Lancet. 338, 1127–1130.CrossRefGoogle ScholarPubMed
van Houwelingen, H. C., Zwindarman, K. H., & Stijnen, T. (1993) A bivariate approach to meta-analysis. Statistic in Medicine. 12, 2273–2284.CrossRefGoogle ScholarPubMed
Wilson, A. & Henry, D. A. (1992) Meta-analysis. Part 2. Assessing the quality of published meta-analyses. Medical Journal of Australia. 156, 173–187.CrossRefGoogle ScholarPubMed
Woolf, B. (1955) On estimating the relation between Wood group and disease. Annals of Human Genetics. 19, 251–253.CrossRefGoogle Scholar
Young, J. P. R., Coleman, A. & Lader, M. H. (1987) A controlled comparison of fluoxetine and amitriptyline in depressed out-patients. British Journal of Psychiatry, 151, 337–340.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.